FF:0000501: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{F5terms
|id=FF:0000501
|name=J2E erythroblastic leukemia line 45min after treatment with erythropoietin
|namespace=FANTOM5
|def=
|xref=
|is_a=EFO:0001746;;FF:0000337;;...") |
No edit summary |
||
Line 14: | Line 14: | ||
|obo_creation_date= | |obo_creation_date= | ||
|subset= | |subset= | ||
|derives_from= | |derives_from= | ||
|develops_from= | |develops_from= |
Revision as of 14:14, 27 June 2012
outline
- id: FF:0000501
- name: J2E erythroblastic leukemia line 45min after treatment with erythropoietin
- namespace: FANTOM5
- CAGEd oPOSSUM: NA
Ontology association
Parents
is_a: | EFO:0001746(development or differentiation design),FF:0000337(erythropoietin treatment sample),FF:0000347(45 minutes sample),FF:0000350(experimentally modified sample),FF:0000403(mouse J2E erythroblastic leukemia cell line sample) |
---|
Children
is a: | FF:13066-139I6 (J2E erythroblastic leukemia response to erythropoietin),FF:13132-140G9 (J2E erythroblastic leukemia response to erythropoietin),FF:13198-141F3 (J2E erythroblastic leukemia response to erythropoietin) |
---|
FF Samples
Mouse
- 13066-139I6 (J2E erythroblastic leukemia response to erythropoietin)
- 13132-140G9 (J2E erythroblastic leukemia response to erythropoietin)
- 13198-141F3 (J2E erythroblastic leukemia response to erythropoietin)